Skip to content

Agilon Health AGL EBITDA margin

EBITDA margin at other companies

CVS Health logo
CVS HealthCVS
2.6%-1.2pp
Astrana Health logo
Astrana HealthASTH
4%-0.9pp
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
2.1%+0.5pp
Alignment Healthcare logo
Alignment HealthcareALHC
1.6%+1.1pp
Clover Health Investments logo
Clover Health InvestmentsCLOV
-2.5%+4.1pp
Elevance Health logo
Elevance HealthELV
4.6%-1.1pp

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.86B-92.6%
Enterprise value$1.69B-103%
P/S0.3×-3.9×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Calculated from Agilon Health’s reported figures.

Based on trailing twelve months.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's EBITDA margin?
Agilon Health (AGL) reported EBITDA margin of -7% in Q1 2026.
How has Agilon Health's EBITDA margin changed year-over-year?
Agilon Health's EBITDA margin decreased by 49.3% year-over-year, from -4.7% to -7%.
What is the long-term trend for Agilon Health's EBITDA margin?
Over 5 years (2020 to 2025), Agilon Health's EBITDA margin has grown at a 16.0% compound annual growth rate (CAGR), from -3.5% to -7.3%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.